Tentative interpretive criteria for testing the susceptibility of Strepococcus pneumoniae to eight fluoroquinolones

Diagnostic Microbiology and Infectious Disease

Volumn 26, Issue 1, 1996, Pages 23-27

  Fuchs, Peter C ^a   Barry, Arthur L ^a   Brown, Steven D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; CIPROFLOXACIN; CLINAFLOXACIN; FLEROXACIN; GREPAFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 0030249966     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00161-7     Document Type: Article

References (12)

1. Barry AL, Fuchs PC (1996) Are ciprofloxacin susceptibility tests relevant for Streptococcus pneumoniae? J Antimicrob Chemother 38:151-153.
2. Barry AL, Fuchs PC, Allen SD, Brown SD, Jorgensen JH, Tenover FC (1996) In vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: Interpretive criteria and quality control limits. J Antimicrob Chemother 37:365-369.
3. Barry AL, Fuchs PC, Allen SD, Tenover FC, Jorgensen JH, Reller LB (1995) Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628. J Clin Microbiol 33:235-238.
4. Fuchs PC, Barry AL, Brown SD, Sewell DL (1996) In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin. Eur J Clin Microbiol Infect Dis 15:678-682.
5. Fuchs PC, Barry AL, Pfaller MA (1993) Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin. J Clin Microbiol 31:2236-2237.
6. Fuchs PC, Barry AL, Pfaller MA (1994) Antibacterial activity of PD131628 and proposed disk diffusion susceptibility test criteria. J Antimicrob Chemother 33:1147-1154.
7. Fuchs Pc, Jones RN, Barry AL, Ayers LW, Gavan TL, Gerlach EH, Thornsberry C (1987) Ro 23-6240 (AM-833), a new fluoroquinolone: In vitro antimicrobial activity and tentative disk diffusion interpretive criteria. Diagn Microbiol Infect Dis 7:29-35.
8. Jones RN, Erwin ME, Barrett MS (1992) Interpretive criteria for CI-960 (AM-1091, PD1127391) disk diffusion tests using 5-μg disks. Diagn Microbiol Infect Dis 15:379-381.
9. National Committee for Clinical Laboratory Standards (1993a) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A3. National Committee for Clinical Laboratory Standards, Wayne, PA.
10. National Committee for Clinical Laboratory Standards (1993b) Performance standards for antimicrobial disk susceptibility tests. M2-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
11. National Committee for Clinical Laboratory Standards (1995) Performance standards for antimicrobial susceptibility testing. M100-S5. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Waites K, Rand K, Jenkins S, Yangco B, Brookings E, Gaskins D, Lewis J, Halkias K (1994) Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical use. Diagn Microbiol Infect Dis 18:181-189.